Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
The closing price of Beta Bionics Inc (NASDAQ: BBNX) was $17.96 for the day, down -3.91% from the previous closing price of $18.69. In other words, the price has decreased by -$3.91 from its previous closing price. On the day, 0.7 million shares were traded.
Ratios:
Our analysis of BBNX’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 14.93 and its Current Ratio is at 15.88. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.02.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Wolfe Research on May 30, 2025, initiated with a Outperform rating and assigned the stock a target price of $20.
On May 30, 2025, Goldman started tracking the stock assigning a Neutral rating and target price of $16.
On February 24, 2025, Stifel started tracking the stock assigning a Buy rating and target price of $25.Stifel initiated its Buy rating on February 24, 2025, with a $25 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jan 31 ’25 when Mensinger Mike bought 33,350 shares for $17.00 per share. The transaction valued at 566,950 led to the insider holds 59,019 shares of the business.
Mensinger Mike sold 13 shares of BBNX for $221 on Jan 31 ’25. The Chief Product Officer now owns 25,669 shares after completing the transaction at $17.00 per share. On Jan 31 ’25, another insider, Wellington Hadley Harbor Aggre, who serves as the 10% Owner of the company, bought 1,000,000 shares for $17.00 each. As a result, the insider paid 17,000,000 and bolstered with 3,901,599 shares of the company.
Stock Price History:
Over the past 52 weeks, BBNX has reached a high of $24.50, while it has fallen to a 52-week low of $8.89. The 50-Day Moving Average of the stock is 40.58%, while the 200-Day Moving Average is calculated to be 15.09%.
Shares Statistics:
A total of 43.35M shares are outstanding, with a floating share count of 33.22M. Insiders hold about 23.38% of the company’s shares, while institutions hold 83.50% stake in the company.
Earnings Estimates
As of right now, 6 analysts gave their recommendation on the stock of the company. The consensus estimate for the next quarter is -$0.44, with high estimates of -$0.37 and low estimates of -$0.61.
Analysts are recommending an EPS of between -$1.92 and -$2.86 for the fiscal current year, implying an average EPS of -$2.25. EPS for the following year is -$2.13, with 6.0 analysts recommending between -$1.6 and -$3.06.
Revenue Estimates
For the next quarter, 8 analysts are estimating revenue of $21.64M. There is a high estimate of $22.81M for the next quarter, whereas the lowest estimate is $21M.
A total of 8 analysts have provided revenue estimates for BBNX’s current fiscal year. The highest revenue estimate was $86.75M, while the lowest revenue estimate was $83M, resulting in an average revenue estimate of $84.79M. In the same quarter a year ago, actual revenue was $65.12MBased on 8 analysts’ estimates, the company’s revenue will be $115.81M in the next fiscal year. The high estimate is $120M and the low estimate is $107.7M.
